Publication | Open Access

Quality by Design as a risk-based strategy in pharmaceutical analysis: Development of a liquid chromatography-tandem mass spectrometry method for the determination of nintedanib and its impurities

Gas ChromatographyMedicineDrug PurityBioanalysisMass SpectrometryRisk-based StrategyPharmaceutical AnalysisToxicologyAnalytical ChemistryLiquid ChromatographyChromatographic AnalysisPharmacologyChromatographyDrug Analysis